Kang Luo

1.8k total citations · 1 hit paper
7 papers, 1.4k citations indexed

About

Kang Luo is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Kang Luo has authored 7 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 3 papers in Hepatology and 2 papers in Molecular Biology. Recurrent topics in Kang Luo's work include Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Kang Luo is often cited by papers focused on Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Kang Luo collaborates with scholars based in China, France and Australia. Kang Luo's co-authors include Satawat Thongsawat, Robert Flisiak, Patrick Marcellin, Wan Cheng Chow, Seung Woon Paik, Philip McCloud, George Lau, Thomas Berg, Edward Gane and Graham Cooksley and has published in prestigious journals such as New England Journal of Medicine, Molecules and Food and Chemical Toxicology.

In The Last Decade

Kang Luo

7 papers receiving 1.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

2005 1.1k citations George Lau, Teerha Piratvisuth et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kang Luo China	5	1.1k	1.1k	129	114	92	7	1.4k
Parviz Parvaz France	14	651 0.6×	621 0.6×	31 0.2×	21 0.2×	163 1.8×	27	1.1k
Eric R. Lemmer South Africa	17	168 0.1×	248 0.2×	21 0.2×	50 0.4×	371 4.0×	27	988
Olga A. Khomich Russia	5	160 0.1×	111 0.1×	8 0.1×	79 0.7×	142 1.5×	9	495
E. Löser Germany	9	116 0.1×	153 0.1×	72 0.6×	18 0.2×	95 1.0×	16	478
Charmaine Lim United States	7	243 0.2×	313 0.3×	3 0.0×	53 0.5×	90 1.0×	9	618
J K Limdi United Kingdom	4	159 0.1×	84 0.1×	13 0.1×	52 0.5×	90 1.0×	13	496
Qiao Wang United States	15	159 0.1×	74 0.1×	77 0.6×	20 0.2×	296 3.2×	27	821
Daniel M. Chopyk United States	7	215 0.2×	94 0.1×	7 0.1×	25 0.2×	256 2.8×	8	525
Zelin Gu China	11	334 0.3×	89 0.1×	5 0.0×	71 0.6×	405 4.4×	16	766
Olja Stevanović Serbia	4	232 0.2×	70 0.1×	8 0.1×	28 0.2×	244 2.7×	7	438

Countries citing papers authored by Kang Luo

Since Specialization

Citations

This map shows the geographic impact of Kang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang Luo more than expected).

Fields of papers citing papers by Kang Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang Luo. The network helps show where Kang Luo may publish in the future.

Co-authorship network of co-authors of Kang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Kang Luo. A scholar is included among the top collaborators of Kang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kang Luo. Kang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Wang, Yang, Yuchen Wu, Kang Luo, et al.. (2013). The protective effects of selenium on cadmium-induced oxidative stress and apoptosis via mitochondria pathway in mice kidney. Food and Chemical Toxicology. 58. 61–67. 146 indexed citations

2.

Ren, Xiangmei, Gaigai Wang, Dongqing Xu, et al.. (2012). The protection of selenium on cadmium-induced inhibition of spermatogenesis via activating testosterone synthesis in mice. Food and Chemical Toxicology. 50(10). 3521–3529. 60 indexed citations

3.

Liu, Yuxin, et al.. (2012). Liquiritigenin Inhibits Tumor Growth and Vascularization in a Mouse Model of Hela Cells. Molecules. 17(6). 7206–7216. 44 indexed citations

4.

Piratvisuth, Teerha, Henry LY Chan, Patrick Marcellin, et al.. (2012). Improved predictive value for sustained immune control in peginterferon alfa-2a (40KD) (PEGASYS)-treated HBeAg-positive patients using combined HBsAg and HBV DNA levels at week 24. 3. 1 indexed citations

5.

Wang, Yu, et al.. (2011). Liquiritigenin Inhibits Serum‐induced HIF‐1α and VEGF Expression via the AKT/mTOR‐p70S6K Signalling Pathway in HeLa Cells. Phytotherapy Research. 26(8). 1133–1141. 28 indexed citations

6.

Lau, George, Teerha Piratvisuth, Kang Luo, et al.. (2005). Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B. New England Journal of Medicine. 352(26). 2682–2695. 1143 indexed citations breakdown →

7.

Liu, Dingxie, et al.. (2002). [Expression of precore and core proteins of hepatitis B virus in human hepatoma cell line].. PubMed. 22(2). 174–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact